American Association of Colleges of Pharmacy (AACP) has scheduled its 2010 American Association of Colleges of Pharmacy Interim meeting February 7-10, 2010. The meeting will take place at the Crystal Gateway Marriott Hotel at 1700 Jefferson Davis Highway in Arlington, Virginia. Speaking during the event will be AACP Executive Vice President and CEO Thomas Menighan, MBA, and Administrator, Health Reasources and Services (HRSA) Mary Wakefield, Ph.D., R.N. Menighan and Wakefield will hold presentations discussing “How can health professions education generally, and academic pharmacy specifically, heighten its commitment to educating collaborative professionals who are competent to meet the needs of both individuals and communities?” The event is free to members of the press. For more information, or to register for the event, contact Rebecca Morgan, director of communications a t703.739.2330 ext. 1032, or rmorgan@aacp.org.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Founded in 1900, the American Association of Colleges of Pharmacy (AACP) is a national organization representing the interests of pharmacy education and educators. Comprising 116 accredited colleges and schools of pharmacy including more than 5,800 faculty, 52,000 students enrolled in professional programs and 5,400 individuals pursuing graduate study, AACP is committed to excellence in pharmacy education.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
